Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan M Granoff

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Infection and Immunity|November 23, 2011
Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidisDavid M Vu, Jutamas Shaughnessy, Lisa A Lewis, et al.
The Journal of Infectious Diseases|February 16, 2006
Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccineDavid M Vu, Jo Anne Welsch, Patricia Zuno-Mitchell, et al.
Infection and Immunity|July 2, 2008
Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding proteinPeter T Beernink, Jo Anne Welsch, Michal Bar-Lev, et al.
The Journal of Infectious Diseases|October 23, 2018
A Meningococcal Native Outer Membrane Vesicle Vaccine With Attenuated Endotoxin and Overexpressed Factor H Binding Protein Elicits Gonococcal Bactericidal AntibodiesPeter T Beernink, Emma Ispasanie, Lisa A Lewis, et al.
The Journal of Infectious Diseases|June 17, 2006
Effectiveness analyses may underestimate protection of infants after group C meningococcal immunizationDavid M Vu, Dominic Kelly, Paul T Heath, et al.
The Journal of Infectious Diseases|April 17, 2007
Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccinePeter T Beernink, Jo Anne Welsch, Lee H Harrison, et al.
The Journal of Infectious Diseases|February 14, 2015
Binding of Complement Factor H (FH) Decreases Protective Anti-FH Binding Protein Antibody Responses of Infant Rhesus Macaques Immunized With a Meningococcal Serogroup B VaccineDan M Granoff, Isabella Costa, Monica Konar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 18, 2011
A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccinationPeter T Beernink, Jutamas Shaughnessy, Emily M Braga, et al.
Clinical and Vaccine Immunology : CVI|August 22, 2014
Fusion protein comprising factor H domains 6 and 7 and human IgG1 Fc as an antibacterial immunotherapeuticJutamas Shaughnessy, David M Vu, Rahi Punjabi, et al.
Clinical and Vaccine Immunology : CVI|November 17, 2016
Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B MeningococciSerena Giuntini, Eduardo Lujan, Malick M Gibani, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Infection and Immunity|November 23, 2011
Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidisDavid M Vu, Jutamas Shaughnessy, Lisa A Lewis, et al.
The Journal of Infectious Diseases|February 16, 2006
Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccineDavid M Vu, Jo Anne Welsch, Patricia Zuno-Mitchell, et al.
Infection and Immunity|July 2, 2008
Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding proteinPeter T Beernink, Jo Anne Welsch, Michal Bar-Lev, et al.
The Journal of Infectious Diseases|October 23, 2018
A Meningococcal Native Outer Membrane Vesicle Vaccine With Attenuated Endotoxin and Overexpressed Factor H Binding Protein Elicits Gonococcal Bactericidal AntibodiesPeter T Beernink, Emma Ispasanie, Lisa A Lewis, et al.
The Journal of Infectious Diseases|June 17, 2006
Effectiveness analyses may underestimate protection of infants after group C meningococcal immunizationDavid M Vu, Dominic Kelly, Paul T Heath, et al.
The Journal of Infectious Diseases|April 17, 2007
Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccinePeter T Beernink, Jo Anne Welsch, Lee H Harrison, et al.
The Journal of Infectious Diseases|February 14, 2015
Binding of Complement Factor H (FH) Decreases Protective Anti-FH Binding Protein Antibody Responses of Infant Rhesus Macaques Immunized With a Meningococcal Serogroup B VaccineDan M Granoff, Isabella Costa, Monica Konar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 18, 2011
A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccinationPeter T Beernink, Jutamas Shaughnessy, Emily M Braga, et al.
Clinical and Vaccine Immunology : CVI|August 22, 2014
Fusion protein comprising factor H domains 6 and 7 and human IgG1 Fc as an antibacterial immunotherapeuticJutamas Shaughnessy, David M Vu, Rahi Punjabi, et al.
Clinical and Vaccine Immunology : CVI|November 17, 2016
Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B MeningococciSerena Giuntini, Eduardo Lujan, Malick M Gibani, et al.
Pageof 10